(Reuters) – U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday, citing people it said were familiar with the matter. The report said deliberations were still at an early stage following Johnson & Johnson's (J&J) initial offer, and Actelion was working with an adviser to explore options. Actelion declined to comment.
Read the original:
J&J makes takeover approach for Swiss drugmaker Actelion: Bloomberg